期刊文献+

前列腺癌根治术前MRI结果对术后生化复发的预测价值研究 被引量:1

Study on the predictive value of preoperative magnetic resonance imaging for biochemical recurrence after radical prostatectomy
下载PDF
导出
摘要 目的研究前列腺癌根治术(RP)前行磁共振成像(MRI)预测术后生化复发的价值。方法选取2006—2013年115例行RP且未接受辅助放化疗的前列腺癌患者,根据其影像资料将其分为MRI阳性组87例,MRI阴性组28例,比较2组的术前临床资料。以术后前列腺特异性抗原(PSA)数值连续2次上升超过0.2μg/L定义为生化复发(38例),应用Cox比例风险回归筛选与生化复发相关的危险因素。结果 MRI阳性组生存时间短于MRI阴性组,术前PSA水平高于阴性组(P<0.05),2组年龄差异无统计学意义。MRI阳性组术前PSA>20μg/L者的比例、临床分期为T3期的比例、病理Gleason评分≥8的比例、存在精囊侵犯(SVI)者的比例及内分泌治疗的比例均高于MRI阴性组(P<0.05)。经单因素分析发现术前MRI阳性、术前PSA水平、活检Gleason评分、临床分期、病理Gleason评分、SVI和淋巴结侵犯(LNM)与患者术后生化复发有关(P<0.05)。进一步多因素Cox分析认为术前MRI阳性、活检Gleason评分高和临床分期高是RP后生化复发的危险因素(P<0.05)。结论术前MRI影像诊断有助于更好地预测RP后生化复发,改善前列腺癌患者的预后。 Objective To evaluate the suitability of preoperative magnetic resonance imaging (MRI) positivity as a pre?dictor of biochemical recurrence after radical prostatectomy (RP). Methods Data of 115 diagnosed prostate cancer patients with RP from 2006 to 2013 were collected retrospectively. According to MRI results, patients were divided into MRI positive group (n=87) and MRI negative group (n=28). The preoperative clinical data were compared between two groups. Biochemi?cal recurrence was defined as increase or persistence of serum prostate specific antigen (PSA) levels>0.2μg/L after surgery. Cox proportional hazard regression model was used to analyze the risk factors associated with biochemical recurrence. Re?sults The survival time was shorter in MRI positive group than that of MRI negative group. The preoperative PSA level was higher in MRI positive group than that of MRI negative group (P<0.05). There was no significant difference in the age of pa?tients between two groups. In MRI positive group, the proportion of preoperative PSA>20μg/L , the proportion of patients at clinical stage T3, the proportion of patients with pathological Gleason score≥8, the proportion of patients with seminal vesi?cle invasion (SVI) and the proportion of patients with endocrine therapy were higher than those of negative group ( P<0.05). The univariate analysis showed that preoperative MRI positivity, PSA level, biopsy Gleason score, clinical stage, pathological Gleason score, SVI level and lymph node invasion (LNM) were associated with biochemical recurrence (P<0.05).However, the multivariate analysis showed that only preoperative MRI positivity, biopsy Gleason score and clinical stage were indepen?dent prognostic factors (P<0.05). Conclusion Preoperative MRI positivity can predict biochemical recurrence after RP successfully, and improve the prognosis of patients.
出处 《天津医药》 CAS 2016年第6期740-743,共4页 Tianjin Medical Journal
基金 天津市科技计划项目(12ZCDZSY17200)
关键词 前列腺肿瘤 前列腺癌切除术 复发 磁共振成像 生存分析 prostatic neoplasms carcinoma prostatectomy recurrence magnetic resonance imaging survival analysis
  • 相关文献

参考文献16

  • 1叶定伟,李长岭.前列腺癌发病趋势的回顾和展望[J].中国癌症杂志,2007,17(3):177-180. 被引量:119
  • 2Simsir A,Cal C,Mammadov R,et al. Biochemical recurrence afterradical prostatectomy:is the disease or the surgeon to blame-[J].Int Braz J Urol,2011,37(3):328-334.
  • 3Kattan MW,Eastham JA,Stapleton AM,et al. A preoperative nomo.gram for disease recurrence following radical prostatectomy for pros.tate cancer[J]. J Natl Cancer Inst,1998,90(1):766-771.
  • 4Cooperberg MR,Pasta DJ,Elkin EP,et al. The University of California,San Francisco Cancer of the Prostate Risk Assessment score:astraightforward and reliable preoperative predictor of disease recur.rence after radical prostatectomy[J]. J Urol,2005,173(6):1938-1942.
  • 5Rarentsz JO,Richenberg J,Clements R,et al. ESUR prostate MRguidelines 2012[J]. Eur Radiol,2012,22(4):746-757.
  • 6Cookson MS,Aus G,Burnett AL,et al. Variation in the definition ofbiochemical recurrence in patients treated for localized prostate can.cer:the American Urological Association Prostate Guidelines for Lo.calized Prostate Cancer Update Panel report and recommendationsfor a standard in the reporting of surgical outcomes[J]. J Urol,2007,177(2):540-545.
  • 7Divrik RT,Eroglu A,Sahin,A,et al. Increasing the number of biopsiesincreases the concordance of Gleason scores of needle biopsies andprostatectomy specimens[J]. Urol Oncol,2007,25(5):376-382.
  • 8Kv.le R,M.ller B,Wahlqvist R,et al. Concordance between Glea.son scores of needle biopsies and radical prostatectomy specimens:a population-based study[J]. BJU Int,2009,103(12):1647-1654.doi:10.1111/j.1464-410X.2008.08255.x.
  • 9Lattouf JB,Saad F. Gleason score on biopsy:is it reliable for predictingthe final grade on pathology-[J]. BJU Int,2002,90(7):694-698.
  • 10王海峰,高旭,王燕,鲁欣,马春飞,施振凯,杨波,盛夏,许传亮,侯建国,孙颖浩.Kattan列线图和CAPRA评分预测中国前列腺癌患者根治术后生化复发的效能验证[J].中华泌尿外科杂志,2015,36(4):285-289. 被引量:8

二级参考文献32

  • 1邵常霞,项永兵,刘振伟,高静,孙璐,方茹蓉,阮志贤,高立峰,金凡,高玉堂.上海市区泌尿系统恶性肿瘤相对生存率分析[J].中国肿瘤临床,2005,32(6):321-324. 被引量:31
  • 2叶定伟.前列腺癌的流行病学和中国的发病趋势[J].中华外科杂志,2006,44(6):362-364. 被引量:168
  • 3叶定伟,李长岭.前列腺癌发病趋势的回顾和展望[J].中国癌症杂志,2007,17(3):177-180. 被引量:119
  • 4Shariat SF, Karakiewicz PI, Roehrbom CG, et al. An updatedcatalog of prostate cancer predictive tools [ J]. Cancer, 2008, 113 : 3075-3099.
  • 5Kattan MW, Eastham JA, Stapleton AM, et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer [J]. J Natl Cancer Inst, 1998, 90: 766-771.
  • 6Cooperberg MR, Pasta DJ, Elkin EP, et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of di- sease recurrence after radical prostatectomy [ J]. J Urol, 2005, 173: 1938-1942.
  • 7Kamiya N, Suzuki H, Nishimura K, et al. Development of nomo- gram to non-steroidal antiandrogen sequential alternation in pros- tate cancer for predictive model [ J]. Jpn J Clin Oncol, 2014, 44 : 263-269.
  • 8Punnen S, Freedland SJ, Presti JC Jr, et al. Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy [ J ]. Eur Urol, 2014, 65: 1171-1177.
  • 9Cookson MS, Aus G, Burnett AL, et al. Variation in the defini- tion of biochemical recurrence in patients treated for localized prostate cancer: the Amerlean Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical out- comes [J]. J Urol, 2007, 177: 540-545.
  • 10Siegel R, MaJ, Zou Z, et al. Cancer statistics, 2014 [J]. CA Cancer J Clin, 2014, 64: 9-29.

共引文献137

同被引文献21

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部